0001179110-17-015217.txt : 20171211
0001179110-17-015217.hdr.sgml : 20171211
20171211170822
ACCESSION NUMBER: 0001179110-17-015217
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171207
FILED AS OF DATE: 20171211
DATE AS OF CHANGE: 20171211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Knowlton Calvin H
CENTRAL INDEX KEY: 0001685833
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37888
FILM NUMBER: 171250185
MAIL ADDRESS:
STREET 1: 228 STRAWBRIDGE DRIVE
STREET 2: SUITE 100
CITY: MOORESTOWN
STATE: NJ
ZIP: 08057
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tabula Rasa HealthCare, Inc.
CENTRAL INDEX KEY: 0001651561
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 465726437
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 228 STRAWBRIDGE DRIVE
STREET 2: SUITE 100
CITY: MOORESTOWN
STATE: NJ
ZIP: 08057
BUSINESS PHONE: 866-648-2767
MAIL ADDRESS:
STREET 1: 228 STRAWBRIDGE DRIVE
STREET 2: SUITE 100
CITY: MOORESTOWN
STATE: NJ
ZIP: 08057
4
1
edgar.xml
FORM 4 -
X0306
4
2017-12-07
0
0001651561
Tabula Rasa HealthCare, Inc.
TRHC
0001685833
Knowlton Calvin H
228 STRAWBRIDGE DRIVE
SUITE 100
MOORESTOWN
NJ
08057
1
1
1
0
Chief Executive Officer
Common Stock
2017-12-07
4
S
0
8000
27.72
D
910362
D
Common Stock
2017-12-08
4
S
0
57500
25.85
D
852862
D
Common Stock
2017-12-08
4
S
0
57500
25.85
D
817617
I
Held by spouse.
This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2017.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.35 to $28.02, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (2) to this Form 4.
The sale of these shares was effected as part of an underwritten public offering completed on December 8, 2017 of common stock of the Company in which the Reporting Person was a selling stockholder.
The price represents the public offering price of $27.50 less the underwriters' discount.
/s/ Brian W. Adams, Attorney-in-fact
2017-12-11